Role of Edaravone as a Treatment Option for Patients with Amyotrophic Lateral Sclerosis
Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s disease, is a progressive and fatal neurodegenerative disease that leads to a loss of muscle control due to nerve cells being affected in the brain and spinal cord. Some of the common clinical presentations of ALS include weakness of mu...
Main Authors: | HaEun Cho, Surabhi Shukla |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/14/1/29 |
Similar Items
-
A New Treatment Option for Amyotrophic Lateral Sclerosis: Edaravone
by: Erdi Şahin
Published: (2018-03-01) -
Edaravone: A new hope for patients with amyotrophic lateral sclerosis
by: Shivangi Garg, et al.
Published: (2019-01-01) -
Efeitos neuroprotetores do Edaravone na hidrocefalia experimental induzida em ratos Wistar
by: Camila Araújo Bernardino Garcia
Published: (2015) -
Efeitos neuroprotetores do Edaravone na hidrocefalia experimental induzida em ratos Wistar
by: Garcia, Camila Araújo Bernardino
Published: (2015) -
Neuroprotective effect of edaravone in experimental glaucoma model in rats: a immunofluorescence and biochemical analysis
by: Arzu Toruk Aksar, et al.
Published: (2015-04-01)